Tranexamic acid in trauma: A joint position statement and resource document of NAEMSP, ACEP, and ACS-COT – PMC

Prehospital use of tranexamic acid (TXA) has grown substantially over the past decade despite contradictory evidence supporting its widespread use. Since the previous guidance document on the prehospital use of TXA for injured patients was published … — Read on pmc.ncbi.nlm.nih.gov/articles/PMC12363306/

Prehospital tranexamic acid is associated with a survival benefit without an increase in complications: Results of two harmonized randomized clinical trials – PMC

A secondary analysis was performed using harmonized data from two large, double-blinded, randomized prehospital TXA trials. Prehospital TXA is safe and independently associated with a dose-dependent lower 28-day mortality risk and lower 24-hour red … — Read on pmc.ncbi.nlm.nih.gov/articles/PMC11422517/

Tranexamic saves lives in post partum bleeding!

Tranexamic acid reduces death due to bleeding in women with post-partum haemorrhage – findings from the #WOMANTrial https://t.co/Lq4vdhSH6p pic.twitter.com/L3HWvgTXsk — The Lancet (@TheLancet) April 26, 2017 #TXA reduced deaths of mothers caused by bleeding after #childbirth by 1/3 https://t.co/VHEVsfDXgp @TheLancet @gatesfoundation #WOMANtrial pic.twitter.com/7uk6B7F5LG — LSHTM press (@LSHTMpress) April 26, 2017

The Clot Module

From Dr Chris Denny, Auckland HEMS Medical Director: Dear colleagues, 1. We need your help. We are testing a new clinical module: The ‘Clot Module.’ Why do we want another module? To borrow an ergonomic phrase – to task cluster. 2. Please read this article (password-protected for Auckland HEMS team members only) from the 2014 Annals ofContinue reading “The Clot Module”